Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection

Journal of Hepatology, Supplement

Volumn 22, Issue 1, 1995, Pages 110-114

  Davis, G L ^a   Lau, J Y N ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Hepatitis C; Interferon

Indexed keywords

ALPHA INTERFERON; ENDOGENOUS COMPOUND; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS C; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION;

CHRONIC DISEASE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON TYPE I, RECOMBINANT; POLYMERASE CHAIN REACTION; RNA, VIRAL; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 0028942770     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)